Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model

Tumor Biology

Volumn 36, Issue 3, 2015, Pages 1667-1678

  Ahmed, Hanaa H ^a   Shousha, Wafaa Gh ^b   Shalby, Aziza B ^a   El Mezayen, Hatem A ^b   Ismaiel, Nora N ^a   Mahmoud, Nadia S ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Helwan University   (Egypt)

Author keywords

Angiogenesis; Apoptosis; Curcumin; Hepatocellular carcinoma; Proliferation; Rat

Indexed keywords

ALPHA FETOPROTEIN; ANGIOGENESIS INHIBITOR; ANTIOXIDANT; CURCUMIN; CYCLINE; GAMMA GLUTAMYLTRANSFERASE; HEAT SHOCK PROTEIN; KI 67 ANTIGEN; TUMOR MARKER;

ANIMAL; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DNA FRAGMENTATION; DOWN REGULATION; DRUG EFFECTS; LIVER; LIVER NEOPLASMS; MALE; METABOLISM; RAT; UPREGULATION; WISTAR RAT;

ALPHA-FETOPROTEINS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CURCUMIN; DNA FRAGMENTATION; DOWN-REGULATION; GAMMA-GLUTAMYLTRANSFERASE; HEAT-SHOCK PROTEINS; KI-67 ANTIGEN; LIVER; LIVER NEOPLASMS; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84930913375     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2767-2     Document Type: Article

References (72)

1. Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, et al. Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2012;9:530–8.
2. Herbst DA, Reddy KR. Risk factors for hepatocellular carcinoma. Clin Liver Dis. 2012;1:180–2.
3. Taha MME, Abdel Wahab SI, Othman F, Hanachi P, Abdul AB, Al-Zubairi AS. In vivo anti-tumor effects of Azadirachta indica in rat liver cancer. Res J Biol Sci. 2009;4:48–53.
4. Subbaraj GK, Kulanthaivel L, Rajendran R, Veerabathiran R. Ethanolic extract of Carum carvi (EECC) prevents N-nitrosodiethylamine induced phenobarbital promoted hepatocarcinogenesis by modulating antioxidant enzymes. Int J Pharm Pharm Sci. 2013;5:195–9.
5. El-Shemey WM, Desouky OS, Mohammed MS, Elsayed AA, El-Houseini ME. Characterization of cirrhosis and hepatocellular carcinoma using low-angle x-ray scattering signatures of serum. Phys Med Biol. 2003;48:239–46.
6. Hussein MM, Ibrahim AA, Abdella HM, Montasser IF, Hassan MI. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Indian J Cancer. 2008;45:167–72.
7. Montaser MF, Sakr MA, Khalifa M. Alpha-l-fucosidase as a tumor marker of hepatocellular carcinoma. Arab J Gastroenterol. 2012;13:9–13.
8. Mas VR, Maluf DG, Archer KJ, Yanek KC, Fisher RA. Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation. Transplantation. 2007;84:1262–71.
9. Motalleb G, Hanachi P, Fauziah O, Asmah R. Effect of Berberis vulgaris fruit extract on alpha-fetoprotein gene expression and chemical carcinogen metabolizing enzymes activities in hepatocarcinogenesis rats. Iran J Cancer Prev. 2008;1:33–44.
10. Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol. 2006;12:1175–81.
11. Schueller G, Kettenbach J, Sedivy R, Stift A, Friedl J, Gnant M, et al. Heat shock protein expression induced by percutaneous radiofrequency ablation of hepatocellular carcinoma in vivo. Int J Oncol. 2004;24:609–13.
12. Lin GY, Chen ZL, Lu CM, Li Y, Ping XJ, Huang R. Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients. World J Gastroenterol. 2000;6:234–8.
13. Youssef MI, Maghraby H, Youssef EA, El–Sayed MM. Expression of Ki-67 in hepatocellular carcinoma induced by diethylnitrosamine in mice and its correlation with histopathological alterations. J App Pharm Sci. 2012;2:52–9.
14. Stroescu C, Dragnea A, Ivanov B, Pechianu C, Herlea V, Sgarbura O, et al. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma. J Gastrointestin Liver Dis. 2008;17:411–7.
15. Qin L, Tang Z. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol. 2002;8:385–92.
16. Li P, Li Y, Liu B, Wang W, Wang Y, Li Z. Curcumin inhibits MHCC97H liver cancer cells by activating ROS/TLR-4/caspase signaling pathway. Asian Pac J Cancer Prev. 2014;15:2329–34.
17. Steward WP, Brown K. Cancer chemoprevention: a rapidly evolving field. Br J Cancer. 2013;109:1–7.
18. Zhang X, Chen Q, Wang Y, Peng W, Cai H. Effects of curcumin on ion channels and transporters. Front Physiol. 2014;5:1–6.
19. Darwish HA, El-Boghdady NA. Possible involvement of oxidative stress in diethylnitrosamine induced hepatocarcinogenesis: chemopreventive effect of curcumin. J Food Biochem. 2011;37:353–61.
20. Sreepriya M, Bali G. Chemopreventive effects of embelin and curcumin against N- nitrosodiethylamine/ phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia. 2005;76:549–55.
21. Barnes JM, Paget GE. Mechanisms of toxic action. Prog Med Chem. 1965;4:18–38.
22. Carrasco-Legleu C, Sánchez-Pérez Y, Márquez-Rosado L, Fattel-Fazenda S, Arce-Popoca E, Hernández-García S, et al. A single dose of caffeic acid phenethyl ester prevents initiation in a medium-term rat hepatocarcinogenesis model. World J Gastroenterol. 2006;12:6779–85.
23. Wu X, Yao D, Su X, Tai B, Huang H, Qiu L, et al. Dynamic expression of rat heat shock protein gp96 and its gene during development of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2007;6:616–21.
24. Bancroft JD, Gamble M. Theory and practice of histological techniques. 6th ed. Churchill Livingstone-Elsevier; 2008. p. 433–469.
25. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning—a laboratory manual. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989.
26. Song Y, Jin S, Cui L, Ji X, Yang F. Immunomodulatory effect of Stichopus japonicus acid mucopolysaccharide on experimental hepatocellular carcinoma in rats. Molecules. 2013;18:7179–93.
27. Singhal A, Jayaraman M, Dhanasekaran DN, Kohli V. Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence. Crit Rev Oncol Hematol. 2012;82:116–40.
28. Sun B, Karin M. NF-κB signaling, liver disease and hepatoprotective agents. Oncogene. 2008;27:6228–44.
29. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41:40–59.
30. Cui W, Hu SX, Tang Z, Hu K. In vivo effects of cyclooxygenase-2 deletion on cellular signaling in hepatocellular carcinoma xenografts in nude mice. J Cancer Mol. 2007;3:49–54.
31. Chen B, Ning M, Yang G. Effect of paeonol on antioxidant and immune regulatory activity in hepatocellular carcinoma rats. Molecules. 2012;17:4672–83.
32. Li C, Qian J, Lin J. Purification and characterization of α-l-fucosidase from human primary hepatocarcinoma tissue. World J Gastroenterol. 2006;12:3770–5.
33. El-Shahat M, El-Abda S, Alkafafyb M, El-Khatiba G. Potential chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis in rats: Myrrh (Commiphora molmol) vs. Turmeric (Curcuma longa). Acta Histochem. 2012;114:421–8.
34. Jozkowicz A, Cooke JP, Guevara I, Huk I, Funovics P, Pachinger O, et al. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res. 2001;51:773–83.
35. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D’Acquisto F, et al. The hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood. 2000;95:189–96.
36. Ikeda Y, Taniguchi N. Gene expression of gamma‐glutamyl transpeptidase. Methods Enzymol. 2005;401:408–25.
37. Castellano I, Merlino A. Gamma-glutamyl transpeptidases: structure and function. Springer Briefs Biochem Mol Biol. 2013;13:1–57.
38. Jayakumar S, Madankumar A, Asokkumar S, Raghunandhakumar S, Gokuladhas K, Kamaraj S, et al. Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol Cell Biochem. 2012;360:51–60.
39. Trivedi NP, Rawal UM. Gamma-glutamyl transpeptidase gene organization and expression: a comparative analysis in rat, mouse, pig and human species. Indian J Exp Biol. 2001;39:41–6.
40. Mahmoud EA, El-Bessoumy AA. Effect of curcumin on hematological, biochemical and antioxidant parameters in Schistosoma mansoni infected mice. Int J Sci. 2013;2:1–14.
41. Atsumi T, Murakami Y, Shibuya K, Tonosaki K, Fujisawa S. Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog alpha-diisoeugenol. Anticancer Res. 2005;25:4029–36.
42. Tian F, Fan T, Zhang Y, Jiang Y, Zhang X. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through down-regulating the activation of NF-κB signaling pathway in vitro and in vivo. Acta Biochim Biophys Sin. 2012;44:847–55.
43. Chougala MB, Bhaskar JJ, Rajan MGR, Salimath PV. Effect of curcumin and quercetin on lysosomal enzyme activities in streptozotocin-induced diabetic rats. Clin Nutr. 2012;30:1–7.
44. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, et al. Curcumin containing diet inhibits the diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis. 2000;21:331–5.
45. Chintana P. Role of curcumin on tumor angiogenesis in hepatocellular carcinoma. Nares Univ J. 2008;16:239–54.
46. Shukla Y, Arora A. Suppression of altered hepatic foci development by curcumin in Wistar rats. Nutr Cancer. 2003;45:53–9.
47. Phan TT, See P, Lee ST, Chan SY. Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing. J Trauma. 2001;51:927–31.
48. Moustafa M, Morsi M, Hussein A, AL-Abd E, Abdel-Moneim N. Evaluation of tumor necrosis factor-α (TNF-α), soluble P-selectin (sP-Selectin), gamma-glutamyl transferase (GGT), glutathione S-transferase Pi (GST-Pi) and alpha-fetoprotein (AFP) in patients with hepatocellular carcinoma before and during chemotherapy. Turk J Cancer. 2005;35:5–11.
49. Kusuzaki K, Shinjo H, Murata H, Takeshita H, Hashiguchi S, Nozaki T, et al. Relationship between doxorubicin binding ability and tumor volume decrease after chemotherapy in adult malignant soft tissue tumors in the extremities. Anticancer Res. 2000;20:3813–6.
50. Lee KA, Qiana DZ, Reya S, Wei H, Liud JO, et al. Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. PNAS. 2008;106:2353–8.
51. Jagan S, Ramakrishnan R, Anandakumar P, Kamaraj S, Devaki T. Antiproliferative potential of Gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma. Mol Cell Biochem. 2008;319:51–9.
52. Paunesku T, Mittal S, Protic M, Oryhon J, Korolev SV, Joachimiak A, et al. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol. 2001;77:1007–21.
53. Chuang S, Cheng A, Lin J, Kuo M. Inhibition by curcumin of a diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol. 2000;38:991–5.
54. Jiang M, Yang-Yen HF, Lin JK, Yen JJ. Differential regulation of p53, c-Myc, Bcl2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene. 1996;13:609–16.
55. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB regulated gene products. Cancer Res. 2007;67:3853–61.
56. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 2001;480–481:243–68.
57. Czeczuga-Semeniuk E, Wołczyński S, Dabrowska M, Dziecioł J, Anchim T. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells. Folia Histochem Cytobiol. 2004;42:221–7.
58. Wang X, Wang Q, Lin H, Gu Y, Xu Y. Significance of clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human hepatocellular carcinomas. Afr J Microbiol Res. 2011;5:5607–14.
59. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperon. 2005;10:86–103.
60. Hooper PL, Hooper JJ. Vitamin E and atherosclerosis. Prev Cardiol. 2004;7:144.
61. Saunders LR, Verdin E. Stress response and aging. Science. 2009;323:1021–2.
62. Chun-Hong Q, Yong-Guo L, Jiang W, Hong-Jie HE. Curcumin reverses adriamycin-resistance of thermotolerant hepatocarcinoma cells by down-regulating p-glycoprotein and heat shock protein 70. Prog Biochem Biophys. 2012;39:151–60.
63. Ak T, Gülçin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact. 2008;174:27–37.
64. Zanini C, Giribaldi G, Mandili G, Carta F, Crescenzio N, Bisaro B, et al. Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing’s sarcoma cell lines. J Neurochem. 2007;103:1344–54.
65. Bhatia D, Thoppil RJ, Mandal A, Samtani KA, Darvesh AS, Bishayee A. Pomegranate bioactive constituents suppress cell proliferation and induce apoptosis in an experimental model of hepatocellular carcinoma: role of wnt/β-catenin signaling pathway. Evid Base Compl Alternative Med. 2013;2013:1–15.
66. Mott JL, Gores GJ. Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain3 (BH3) mimetics and cell death. Hepatology. 2007;46:906–11.
67. Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi H. Expression and role of Bcl-XL in human hepatocellular carcinomas. Hepatology. 2001;34:55–61.
68. Lorenzo HK, Susin SA. Mitochondrial effectors in caspase- independent cell death. FEBS Lett. 2004;557:14–20.
69. Park SS, Eom Y, Choi KS. Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe, but not in high dose doxorubicin-induced apoptosis. Biochem Biophys Res Commun. 2005;334:1014–21.
70. Seufi A, Safinz S, Ibrahim S, Elmaghraby TK, Hafez EE. Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences. J Exp Clin Canc Res. 2009;28:80–6.
71. Syng-Ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther. 2004;3:1101–8.
72. El-Sayyad H, Ismail MF, Shalaby FM, Abou-El-Magd RF, Gau RL, Fernando A, et al. Histopathological effects of cisplatin, doxorubicin and 5-fluorouracil (5-FU) on the liver of male albino rats. Int J Biol Sci. 2009;5:466–73.